AI Bias Page, Health Equity Discussion Paper Back On FDA Site

Two US FDA device center websites have been restored under a restraining order. The pages now carry a disclaimer alleging they include "extremely inaccurate" content about gender; however, neither site includes any substantive discussion of trans issues.

Multicolored wooden blocks with human symbols, representing diversity.
(jd8/Shutterstock)

Two US Food and Drug Administration websites addressing health equity in a medical device context have been restored following legal action.

The pages, “Identifying and Measuring Artificial Intelligence (AI) Bias for Enhancing Health Equity” and “Discussion Paper: Health Equity For Medical Devices,” were taken down as part of President Trump’s efforts to purge content supporting certain forms of diversity, equity and inclusion (DEI) from government publications. A public health group called

More from Medtech Insight

More from Legal & IP